Riskpilot← Back to searchSign inGet full accessSjälsmedjan AB
ABActiveOrg 5592746506Breitenfeldsgatan 5Other education n.e.c. · NACE 8559Est. 20201-4 employees
Revenue 2025
SEK 1,6M
+23% vs 2024
EBITDA margin
75.7%
+26% vs 2024
Equity ratio
77.1%
Financial strength
Net profit 2025
SEK 946K
+27% vs 2024
| Revenue | SEK 1,6M | +23% |
| EBITDA | SEK 1,2M | +26% |
| Net profit | SEK 946K | +27% |
| Total assets | SEK 1,8M | +72% |
| Equity | SEK 1,4M | +81% |
| Employees | — | — |
Legal name
Själsmedjan AB
Org number
5592746506
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
2 oktober 2020
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva psykoterapiverksamhet och arbete som specialistläkare. Dessutom uppdrag inom utbildning, handledning, forskning och därmed förenlig verksamhet, inklusive handel med värdepapper.
Address
Breitenfeldsgatan 5
Email
arwa.josefsson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10 | 464 | 789 | 1 270 | 1 565 |
| Staff expenses | — | −59 | −53 | −76 | −122 |
| EBITDA | 10 | 320 | 565 | 939 | 1 185 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 10 | 320 | 565 | 939 | 1 185 |
| Net financials | — | — | 2 | 1 | 7 |
| Profit before tax | 10 | 320 | 566 | 940 | 1 192 |
| Tax | −2 | −67 | −118 | −195 | −246 |
| Net profit | 8 | 253 | 449 | 745 | 946 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 38 | 467 | 747 | 1 056 | 1 812 |
| Equity | 33 | 286 | 475 | 770 | 1 397 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 5 | 182 | 272 | 286 | 415 |
| Total debt | 5 | 182 | 272 | 286 | 415 |
EBITDA margin
75.7%
This company
15.8%
Market median
+379% vs market
20212025
Equity ratio
77.1%
This company
38.2%
Market median
+102% vs market
20212025
Return on equity
67.7%
This company
18.4%
Market median
+268% vs market
20212025
Net profit margin
60.4%
This company
8.1%
Market median
+646% vs market
20212025
Asset turnover
0.86×
This company
1.12×
Market median
+23% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Själsmedjan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arwa Marie Josefsson | Board of Directors | 0 companies |
| Karl Håkan Josefsson | Deputy Board Member | 0 companies |